EUVIMEDScopri EUVIMED
Multizentrische Studie

The Impact of “Close Margins” in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma Treated With TORS

Gabriela A Calcano iD, Katelyn S Rourk, David M Routman, Jamie J O'Byrne, Ashish V Chintakuntlawar, Joaquin J Garcia, Daniel L Price, Kendall K Tasche, Eric J Moore, Kathryn M Van Abel iD, Linda X Yin iD

Otolaryngology–Head and Neck Surgery · 2025

DOI: 10.1002/ohn.1127 ↗

At a glance

Multizentrische Studie in Otolaryngology–Head and Neck Surgery, 2025. Written by Gabriela A Calcano and 10 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA. Major MEDLINE topics: Oropharyngeal Neoplasms, Margins of Excision, Papillomavirus Infections, Carcinoma, Squamous Cell. Cited 5 times so far (Crossref); 26 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Objective

Margin distance is a significant prognosticator in oral cavity cancer but its role in HPV‐related oropharyngeal squamous cell carcinoma [HPV(+)OPSCC] remains unclear. Here, we investigate the impact of margin distance on locoregional recurrence in HPV(+)OPSCC. Study Design This is a retrospective cohort study of surgically treated HPV(+)OPSCC patients. Patients received either standard of care (at least 60 Gy with or without cisplatin) or de‐escalated adjuvant therapy (30‐36 Gy with concurrent docetaxel). Margin distance was measured in mm from the primary specimen or in combination with separately submitted margins. Kaplan‐Meier survival analysis with univariate and multivariable Cox regressions were conducted to determine the impact of margin distance on risk of local and locoregional recurrence.

Setting

Setting for this is 3 tertiary centers between January 2010 and February 2024.

Results

Among 1102 included patients, 33 (3.0%) had positive final margins. 374 patients had adequate margin distance data available. Margin distance was >3 mm in 73.4%, 1 to 3 mm in 24.5%, and .05).

Conclusion

Positive final margins after TORS without adjuvant radiotherapy for HPV(+)OPSCC carries a high risk of local recurrence. Margin distance does not appear to significantly impact risk of local or locoregional recurrence, even after de‐escalated adjuvant radiotherapy.

Subjects

MeSH terms (MEDLINE)

Oropharyngeal NeoplasmsMargins of ExcisionPapillomavirus InfectionsCarcinoma, Squamous CellSquamous Cell Carcinoma of Head and NeckHumansRetrospective StudiesMaleFemaleMiddle AgedNeoplasm Recurrence, LocalAged

Author keywords

close marginslocoregional recurrenceoropharynx cancer

Authors and institutions

  • Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Arizona, USA.
  • Department of Pathology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID profiles: Gabriela A Calcano, Kathryn M Van Abel, Linda X Yin

Cite

APA

Calcano, G. A., Rourk, K. S., Routman, D. M., O'Byrne, J. J., Chintakuntlawar, A. V., Garcia, J. J., Price, D. L., Tasche, K. K., Moore, E. J., Van Abel, K. M., & Yin, L. X. (2025). The Impact of “Close Margins” in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma Treated With TORS. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1127

Vancouver

Calcano GA, Rourk KS, Routman DM, O'Byrne JJ, Chintakuntlawar AV, Garcia JJ, et al. The Impact of “Close Margins” in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma Treated With TORS. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1127

BibTeX
@article{Calcano2025,
  author = {Calcano, Gabriela A and Rourk, Katelyn S and Routman, David M and O'Byrne, Jamie J and Chintakuntlawar, Ashish V and Garcia, Joaquin J and Price, Daniel L and Tasche, Kendall K and Moore, Eric J and Van Abel, Kathryn M and Yin, Linda X},
  title = {The Impact of “Close Margins” in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma Treated With TORS},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2025},
  doi = {10.1002/ohn.1127}
}
Start for free →